As a career statistician turned caregiver for my partner during his successful fight against cancer, I found that both patient and caregiver can actually have control during the ups and downs of chemotherapy – and we’re excited to now bring this valuable tool to anyone with a smartphone or wearable
LOS ANGELES (PRWEB) June 28, 2018
chemoWave, a free app that enables cancer patients to take greater control of their health during treatment, today launched a mobile version compatible on the Android Google Play Store.
The initial iOS version of chemoWave was launched a few weeks after a 2017 report on a clinical trial announced at the American Society of Clinical Oncology (ASCO) Annual Meeting that showed cancer patients lived 20 percent longer when tracking their treatment using digital technology. Now chemoWave can be used on all Android and Apple phones, as well as the Apple Watch or other wearables.
"As a career statistician turned caregiver for my partner during his successful fight against cancer, I found that both patient and caregiver can actually have control during the ups and downs of chemotherapy – and we’re excited to now bring this valuable tool to anyone with a smartphone or wearable," said chemoWave’s co-founder and CEO, Matt Lashey. "chemoWave empowers cancer patients to feel better and avoid things that make them feel worse by revolutionizing the collaboration with their care providers in the tracking and interventions of side effects and symptoms.”
chemoWave is the initial and premier app of Treatment Technologies & Insights, a digital health company that creates in-depth, easy-to-use mobile apps to enhance treatment of chronic medical conditions. Starting with chemoWave, the free apps empower users to track things like symptoms, various activities, and medications, discover correlations, control side effects and share experience data with care providers to make the doctor-patient relationship more efficient. The result is a holistic, real-time record of what the patient experiences, designed to engage patients with more control over treatment side effects, provide doctors with better information for more confident decision-making, and will ultimately improve treatment protocols that lead to better outcomes in the future. In early 2018, TTI launched a collaboration with ASCO’s cancer.net to provide targeted symptom insights for all users - via the chemoWave app - from America’s leading online destination for cancer patients.
Armando Monroy, Lead Engineer for chemoWave and TTI, explained the team’s approach to the Android launch: “We were collaborating as a team and trying to deliver the best personal experience to our future Android users. We know there is not another app like chemoWave out there, so we tried to create the best platform we could to optimize our app for every Android device, even if it meant extra work.”
Read more about the personal story that led to the creation of chemoWave in this month’s American Journal of Managed Care.